================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                          ----------------------------


                                    FORM 8-K



                                 CURRENT REPORT


     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934




        Date of Report (Date of earliest event reported): APRIL 26, 2004





                                IDEX CORPORATION
             (Exact Name of Registrant as Specified in its Charter)




           DELAWARE                       1-10235                36-3555336
(State or other jurisdiction of         (Commission           (I.R.S. Employer
 incorporation or organization)         File Number)         Identification No.)




                                 630 DUNDEE ROAD
                           NORTHBROOK, ILLINOIS 60062
          (Address of principal executive offices, including zip code)



                                 (847) 498-7070
                         (Registrant's telephone number)




================================================================================


ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS

        On April 26, 2004, IDEX Corporation issued a press release announcing
        that it has entered into a definitive agreement to acquire Scivex, Inc.
        A copy of this press release is included below.


         IDEX CORPORATION ENTERS INTO AGREEMENT TO ACQUIRE SCIVEX, INC.

        NORTHBROOK, IL, APRIL 26, 2004 -- IDEX CORPORATION (NYSE: IEX) today
        announced that it has entered into a definitive agreement to acquire
        Scivex, Inc., a leading provider of fluidic components and systems for
        the analytical, biotechnology and diagnostic instrumentation markets.
        Scivex is a portfolio company of KRG Capital Partners, a middle market
        private equity firm based in Denver, Colorado. The transaction is
        subject to certain conditions, including approval under the
        Hart-Scott-Rodino Antitrust Improvements Act. Terms of the cash
        transaction were not disclosed.

        Scivex operates Upchurch Scientific in Oak Harbor, Washington, Sapphire
        Engineering in Pocasset, Massachusetts, and J. L. White in Santa Clara,
        California, and has annual sales of approximately $31 million. Its
        primary products include a wide variety of high tech components
        including fittings, tubing, check valves, pistons, filters as well as
        dispensing pumps, micro and nano-scale fluidic modules. It is expected
        that Scivex will be operated as a standalone business in IDEX's Pump
        Products Group.

        ABOUT IDEX
        IDEX Corporation is the world's leading provider of positive
        displacement pumps, dispensing equipment for color formulation and other
        highly engineered products. Its products are sold to a wide range of
        industries throughout the world. IDEX shares are traded on the New York
        Stock Exchange and Chicago Stock Exchange under the symbol "IEX."

        FORWARD-LOOKING STATEMENTS
        This news release contains forward-looking statements within the meaning
        of Section 27A of the Securities Act of 1933, as amended, and Section
        21E of the Exchange Act of 1934, as amended. These statements are
        indicated by words or phrases such as "anticipate," "estimate," "plans,"
        "expects," "projects," "should," "will," "management believes," "the
        company believes," "the company intends," and similar words or phrases.
        These statements are subject to inherent uncertainties and risks that
        could cause actual results to differ materially from those anticipated
        at the date of this news release. For a discussion of such risks and
        factors that could cause actual results to differ from those contained
        in the forward-looking statements, please see "Risk Factors" in the
        company's annual report or Form 10-K for the most recent fiscal year, as
        well as the company's other filings with the Securities and Exchange
        Commission. Management undertakes no obligation to publicly update the
        forward-looking statements contained in this release. Investors are
        cautioned not to rely unduly on forward-looking statements when
        evaluating the information presented here.


       FOR FURTHER INFORMATION ON IDEX CORPORATION AND ITS BUSINESS UNITS,
               VISIT THE COMPANY'S WEB SITE AT www.idexcorp.com.









                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.







                                      IDEX CORPORATION


                                      /S/ DOMINIC A. ROMEO
                                      ------------------------------------------
                                      Dominic A. Romeo
                                      Vice President and Chief Financial Officer

April 26, 2004